Detalles de la búsqueda
1.
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection.
Gut
; 72(7): 1385-1398, 2023 07.
Artículo
Inglés
| MEDLINE | ID: mdl-36697207
2.
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
N Engl J Med
; 383(19): 1827-1837, 2020 11 05.
Artículo
Inglés
| MEDLINE | ID: mdl-32459919
3.
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.
Ann Intern Med
; 175(9): 1221-1229, 2022 09.
Artículo
Inglés
| MEDLINE | ID: mdl-35939812
4.
Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection.
J Hepatol
; 77(3): 642-652, 2022 09.
Artículo
Inglés
| MEDLINE | ID: mdl-35460726
5.
Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.
J Hepatol
; 77(5): 1265-1275, 2022 11.
Artículo
Inglés
| MEDLINE | ID: mdl-35697332
6.
Acid Suppression Medications During Hospitalization as a Risk Factor for Recurrence of Clostridioides difficile Infection: Systematic Review and Meta-analysis.
Clin Infect Dis
; 73(1): e62-e68, 2021 07 01.
Artículo
Inglés
| MEDLINE | ID: mdl-32386313
7.
Risk Factors and Outcomes of Hospitalized Patients With Severe Coronavirus Disease 2019 (COVID-19) and Secondary Bloodstream Infections: A Multicenter Case-Control Study.
Clin Infect Dis
; 72(12): e995-e1003, 2021 06 15.
Artículo
Inglés
| MEDLINE | ID: mdl-33216875
8.
How Do You Measure Up: Quality Measurement for Improving Patient Care and Establishing the Value of Infectious Diseases Specialists.
Clin Infect Dis
; 68(11): 1946-1951, 2019 05 17.
Artículo
Inglés
| MEDLINE | ID: mdl-30256911
9.
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials.
Gastroenterology
; 153(1): 113-122, 2017 07.
Artículo
Inglés
| MEDLINE | ID: mdl-28390869
10.
Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failure.
Hepatology
; 66(6): 1794-1804, 2017 12.
Artículo
Inglés
| MEDLINE | ID: mdl-28688129
11.
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.
N Engl J Med
; 370(16): 1483-93, 2014 Apr 17.
Artículo
Inglés
| MEDLINE | ID: mdl-24725238
12.
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial.
Gastroenterology
; 151(5): 893-901.e1, 2016 11.
Artículo
Inglés
| MEDLINE | ID: mdl-27486034
13.
Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study.
Hepatology
; 64(2): 370-80, 2016 08.
Artículo
Inglés
| MEDLINE | ID: mdl-26799692
14.
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.
Ann Intern Med
; 165(9): 625-634, 2016 11 01.
Artículo
Inglés
| MEDLINE | ID: mdl-27537841
15.
Linkage to Care for Suburban Heroin Users with Hepatitis C Virus Infection, New Jersey, USA.
Emerg Infect Dis
; 22(5): 907-9, 2016 May.
Artículo
Inglés
| MEDLINE | ID: mdl-27089172
16.
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial.
Lancet
; 385(9973): 1087-97, 2015 Mar 21.
Artículo
Inglés
| MEDLINE | ID: mdl-25467560
17.
Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection.
Gastroenterology
; 149(6): 1462-70, 2015 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-26248087
18.
Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failed.
Hepatology
; 62(1): 129-34, 2015 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-25847509
19.
Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial.
Ann Intern Med
; 163(11): 818-26, 2015 Dec 01.
Artículo
Inglés
| MEDLINE | ID: mdl-26551051
20.
The infectious diseases physician in the future of healthcare: not only about antibiotic prescribing.
Clin Infect Dis
; 60(5): 773-6, 2015 Mar 01.
Artículo
Inglés
| MEDLINE | ID: mdl-25416751